Virtue Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-5,362
| Closed | -$448K | – | 401 |
|
2023
Q4 | $448K | Sell |
5,362
-2,667
| -33% | -$223K | 0.09% | 219 |
|
2023
Q3 | $620K | Hold |
8,029
| – | – | 0.11% | 186 |
|
2023
Q2 | $620K | Buy |
8,029
+1,470
| +22% | +$114K | 0.11% | 186 |
|
2023
Q1 | $549K | Sell |
6,559
-1,462
| -18% | -$122K | 0.09% | 201 |
|
2022
Q4 | $689K | Buy |
+8,021
| New | +$689K | 0.11% | 135 |
|
2022
Q3 | – | Sell |
-4,533
| Closed | -$280K | – | 276 |
|
2022
Q2 | $280K | Sell |
4,533
-2,582
| -36% | -$159K | 0.04% | 198 |
|
2022
Q1 | $423K | Sell |
7,115
-3,554
| -33% | -$211K | 0.07% | 295 |
|
2021
Q4 | $775K | Buy |
10,669
+1,643
| +18% | +$119K | 0.11% | 206 |
|
2021
Q3 | $630K | Sell |
9,026
-714
| -7% | -$49.8K | 0.11% | 214 |
|
2021
Q2 | $671K | Sell |
9,740
-2,270
| -19% | -$156K | 0.13% | 200 |
|
2021
Q1 | $776K | Buy |
12,010
+520
| +5% | +$33.6K | 0.18% | 163 |
|
2020
Q4 | $669K | Sell |
11,490
-2,290
| -17% | -$133K | 0.16% | 169 |
|
2020
Q3 | $871K | Sell |
13,780
-3,038
| -18% | -$192K | 0.21% | 137 |
|
2020
Q2 | $1.29M | Buy |
+16,818
| New | +$1.29M | 0.3% | 98 |
|
2020
Q1 | – | Sell |
-8,921
| Closed | -$580K | – | 100 |
|
2019
Q4 | $580K | Sell |
8,921
-4,381
| -33% | -$285K | 0.17% | 120 |
|
2019
Q3 | $843K | Sell |
13,302
-1,878
| -12% | -$119K | 0.28% | 113 |
|
2019
Q2 | $1.03M | Buy |
+15,180
| New | +$1.03M | 0.37% | 87 |
|
2018
Q4 | – | Sell |
-30,086
| Closed | -$2.32M | – | 145 |
|
2018
Q3 | $2.32M | Buy |
30,086
+14,982
| +99% | +$1.16M | 0.49% | 57 |
|
2018
Q2 | $1.07M | Buy |
15,104
+2,255
| +18% | +$160K | 0.52% | 55 |
|
2018
Q1 | $951K | Buy |
12,849
+1,012
| +9% | +$74.9K | 0.5% | 54 |
|
2017
Q4 | $848K | Buy |
+11,837
| New | +$848K | 0.48% | 29 |
|